EUVIMEDEUVIMED entdecken
Crossref

Risk Factors for Coronavirus Disease 2019 Hospitalization and Vaccination Impact Among Pediatric Solid Organ Transplant Recipients in the United States

Sanya J Thomas, Natalia E Castillo Almeida, Claire Bocchini, Caitlin Brammer, Guy Brock, Abigail Calimaran, Ronald Dallas, Kevin J Downes, Jose A Ferrolino, Md Rejuan Haque, Anna R Huppler, Ishminder Kaur und 17 weitere

Transplant Infectious Disease · 13.08.2026

DOI: 10.1111/tid.70303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 13.08.2026. Verfasst von Sanya J Thomas und 28 weiteren Autor:innen. Beteiligte Einrichtung: Host Defense Program, Section of Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio, USA. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Infectious Diseases Consortium Research Grant from the Abigail Wexner Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While vaccination is a key strategy to mitigate the severity of coronavirus disease 2019 (COVID‐19) in children, the risk factors for symptomatic, medically attended (hereon referred to as “symptomatic”) COVID‐19 and the impact of vaccination are not well defined among pediatric solid organ transplant recipients (PSOTR).

Methods

PSOTR aged six months through 21 years at 11 centers in the Pediatric Infectious Diseases Transplant Network (PIDTRAN) were analyzed retrospectively for symptomatic COVID‐19 between July 2021 and May 2023. Using a Cox proportional hazards model, risk factors associated with COVID‐19‐associated hospitalization, in‐hospital oxygen use, mechanical ventilation, and the impact of COVID‐19 vaccination were analyzed.

Results

Of 1370 PSOTR, 410 (29%) had symptomatic COVID‐19 infection. Among those with symptomatic infection, 115 (28%) were hospitalized, 35 required in‐hospital oxygen, and three required mechanical ventilation. In the study, 45% were unvaccinated against COVID‐19. Compared to unvaccinated PSOTR, incompletely vaccinated PSOTR had 56% lower hazard (95% CI 0.26, 0.72, p = 0.001) of COVID‐19‐associated hospitalization whereas completely vaccinated did not have a statistically significant difference in hazard of hospitalization. Receipt of at least one dose of the bivalent vaccine was also associated with 92.5% lower hazard (95% CI 0.010, 0.55, p = 0.011) of hospitalization. Risk factors for hospitalization included chronic kidney disease, underlying heart disease, neurodevelopmental delay, and lymphocytopenia.

Conclusions

Most PSOTR with symptomatic COVID‐19 did not require hospitalization or respiratory support. Several comorbidities and lymphocytopenia are associated with severe COVID‐19 in PSOTR. COVID‐19 vaccination, mostly, protected PSOTR against COVID‐19‐associated hospitalization, but vaccine uptake among PSOTR was low. image

Schlagwörter

Stichwörter der Autor:innen

COVID‐19pediatricstransplantvaccines

Autor:innen und Institutionen

  • Host Defense Program, Section of Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Division of Infectious Diseases, Department of Pediatrics, Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Pediatric Infectious Diseases, Columbia University Irving Medical Center and New York-Presbyterian - Morgan Stanley Children's Hospital, New York, USA.
  • Division of Infectious Diseases, Department of Pediatrics, Columbia University - Vagelos College of Physicians and Surgeons, New York, USA.
  • Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Förderung

  • Infectious Diseases Consortium Research Grant from the Abigail Wexner Research Institute

Zitieren

APA

Thomas, S. J., Almeida, N. E. C., Bocchini, C., Brammer, C., Brock, G., Calimaran, A., Dallas, R., Downes, K. J., Ferrolino, J. A., Haque, M. R., Huppler, A. R., Kaur, I., Kumar, M., Landry, M., Lerret, S., Maron, G. M., Minniear, T. D., Muller, W. J., Munoz, F. M., …, & Shimamura, M. (2026). Risk Factors for Coronavirus Disease 2019 Hospitalization and Vaccination Impact Among Pediatric Solid Organ Transplant Recipients in the United States. Transplant Infectious Disease. https://doi.org/10.1111/tid.70303

Vancouver

Thomas SJ, Almeida NEC, Bocchini C, Brammer C, Brock G, Calimaran A, et al. Risk Factors for Coronavirus Disease 2019 Hospitalization and Vaccination Impact Among Pediatric Solid Organ Transplant Recipients in the United States. Transplant Infectious Disease. 2026. doi:10.1111/tid.70303

BibTeX
@article{Thomas2026,
  author = {Thomas, Sanya J and Almeida, Natalia E Castillo and Bocchini, Claire and Brammer, Caitlin and Brock, Guy and Calimaran, Abigail and Dallas, Ronald and Downes, Kevin J and Ferrolino, Jose A and Haque, Md Rejuan and Huppler, Anna R and Kaur, Ishminder and Kumar, Madan and Landry, Meghan and Lerret, Stacee and Maron, Gabriela M and Minniear, Timothy D and Muller, William J and Munoz, Flor M and Otto, William R and Perkins, Kerrigan and Ristagno, Elizabeth H and Sharova, Anna and Siegel, Katherine and Song, Eunkyung and Valladares, Marion Jose and Wilson, Natasha A and Yoshida, Allison and Shimamura, Masako},
  title = {Risk Factors for Coronavirus Disease 2019 Hospitalization and Vaccination Impact Among Pediatric Solid Organ Transplant Recipients in the United States},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70303}
}
Kostenlos starten →